Fobumix Easyhaler (formoterol budesonide): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Fobumix Easyhaler 160/4.5 inhalation powder

Fobumix Easyhaler is indicated in adults 18 years of age and older only.

Asthma

Fobumix Easyhaler 160 micrograms/ 4.5 micrograms is indicated for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2-adrenoceptor agonist) is appropriate:

- patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2-adrenoceptor agonists.

or

- patients already adequately controlled on both inhaled corticosteroids and long-acting β2-adrenoceptor agonists.

Chronic Obstructive Pulmonary Disease (COPD)

Fobumix Easyhaler 160 micrograms/ 4.5 micrograms is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with COPD with FEV1 < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy (see also section 4.4).

Fobumix Easyhaler 320/9 inhalation powder

Fobumix Easyhaler is indicated in adults 18 years of age and older only.

Asthma

Fobumix Easyhaler 320 micrograms/ 9 micrograms is indicated for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2-adrenoceptor agonist) is appropriate:

- patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2-adrenoceptor agonists.

or

- patients already adequately controlled on both inhaled corticosteroids and long-acting β2-adrenoceptor agonists.

Chronic Obstructive Pulmonary Disease (COPD)

Fobumix Easyhaler 320 micrograms/ 9 micrograms is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with COPD with FEV1 < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy (see also section 4.4).

Fobumix Easyhaler 80/4.5 inhalation powder

Fobumix Easyhaler is indicated in adults 18 years of age and older only.

Fobumix Easyhaler 80 micrograms/ 4.5 micrograms is indicated for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:

- patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.

or

- patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

Note: Fobumix Easyhaler 80 micrograms/ 4.5 micrograms is not appropriate in patients with severe asthma.


Route of administration: opinion.traitement.inhalation
Molecule: formoterol, budesonide

Patients' opinions on Fobumix Easyhaler

In brief

General satisfaction level: 9.00/10 Learn more

Treatment's effectiveness: 9.00/10 Learn more

Ease of use: 9.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 1.00/10 Learn more

Improvement in the quality of life: 8.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

COPD

See the fact sheet
Fact sheet

Asthma

See the fact sheet